Corticobasal degeneration (CBD) is a rare, fatal, neurodegenerative condition.1 The features of CBD include asymmetrical rigidity, parkinsonism, dystonia, myoclonus, apraxia, cortical sensory loss, and an ‘alien hand’.2 Pathologically, CBS is characterised by plaques formed of tau protein (four-repeat tau) that form within striatal neurones and glial cells.1,2

References:
1.Niccolini F, Politis M. A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism. Eur J Nucl Med Mol Imaging 2016; 43 (12): 2244–2254.

2.Kouri N, Whitwell JL, Josephs KA, et al. Corticobasal degeneration: a pathologically distinct 4R tauopathy. Nat Rev Neurol 2011; 7 (5): 263–272.